SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.April 3, 2015 1:04 p.m. Share
San Diego’s Amplyx Pharmaceuticals is beefing up its executive team and tacking on an additional $8.7 million to its recent Series B round, upping the total for that round to $49.2 million.
Oceanside’s Tri-City Medical Center is partnering with health-tech firm Aidin to ensure that patients stay healthy after going home.
Sente, a specialty aesthetics firm in San Diego, announced that it has raised $5 million in financing.
Johnson & Johnson has partnered with San Diego-based Cue to develop a cheap, portable and Internet-enabled HIV test.
Aethlon Medical Inc., a company that makes a blood-filtering device to treat infectious disease and cancer, reported financial results for its fiscal 2016 third quarter.
Health tech company Aira.IO announced Thursday that it has raised $2.5 million in a Series A round of financing.
A cancer researcher at Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a seven-year, $7.9 million grant to advance his cancer research.
HEALTH: Wellness Programs’ Effectiveness Can Be Difficult to Measure
If you can’t do squats in those pants, don’t wear them to work.
After gobbling up San Diego’s CareFusion in a $12.2 billion deal last year, global medical equipment supplier Becton, Dickinson and Co. has decided to maintain (even grow) its presence in San Diego.
San Diego-based Illumina reported strong growth for its 2015 fiscal year on Tuesday, with net income increasing 31 percent and sales rising 19 percent.
Tandem Diabetes Care Inc., a medical device maker and manufacturer of insulin pumps in San Diego, has announced that Brian Hansen has joined the company as chief commercial officer and executive vice president.
San Diego drugmaker Ligand Pharmaceuticals has entered into a licensing agreement with San Francisco-based Tizona Therapeutics.
Balda C. Brewer Inc. USA, a maker of plastic molds used in medical devices and other products, is closing a plant in Irvine this month and cutting 193 jobs. The company plans to shift more jobs out of OC with the relocation of other operations from Anaheim to the Inland Empire and San Diego County.
San Diego-based sequencing firm Illumina Inc. announced Monday that it has signed four separate biobanking deals with Vanderbilt University, University of Colorado at Denver, Partners HealthCare, and Montreal Heart Institute.
Local drugmaker HUYA Bioscience International inked a licensing deal with Eisai worth up to $280 million-plus, the company announced Monday.